Determining the probability of success of a clinical trial using a prior distribution on the treatment effect can significantly enhance decision-making by the sponsor. In a group sequential design, th
Supplementary Material 1. Supplementary Tables and Supplementary Figures (referenced in the main text as S1-S15), including results for over and under powered simulation settings and a brief sensitivi
